SEROLOGICAL RESPONSES AFTER SARS-COV-2 VACCINATION FIRST DOSE IN PATIENTS WITH LYMPHOID MALIGNANCY: FIRST INTERIM ANALYSIS OF THE UK PROSECO STUDY

Lim, S. H.; Campbell, N.; Joseph-Pietras, D.; Johnson, M.; Mundy, C.; Coleman, H.; Wynn, T.; Maynard, B.; Lown, R.; Bates, A.; Wetherall, N.; Muller, D.; Falconer, J.; Fox, C.; Collins, G.; O'Callaghan, A.; Willimott, V.; Ahearne, M.; Faust, S. N.; Johnson, P. W.; Goldblatt, D.; Davies, A. J.

Lim, S. H.; Campbell, N.; Joseph-Pietras, D.; Johnson, M.; Mundy, C.; Coleman, H.; Wynn, T.; Maynard, B.; Lown, R.; Bates, A.; Wetherall, N.; Muller, D.; Falconer, J.; Fox, C.; Collins, G.; O'Callaghan, A.; Willimott, V.; Ahearne, M.; Faust, S. N.; Johnson, P. W.; Goldblatt, D.; Davies, A. J..

Hematological Oncology ; 39(S2), 2021.

Article in English | Wiley | ID: covidwho-1272191

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Wiley Topics: Vaccines Language: English Journal: Hematological Oncology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google